Medicamen Biotech Limited · NSE:MEDICAMEQ
Medicamen Biotech — Q4 FY22 Earnings Presentation
9 slides from Medicamen Biotech's earnings presentation, March 2022
Slide 1: Medicamen Biotech Limited Q4 FY22 Investor Presentation
Medicamen Biotech Limited Q4 FY22 Investor Presentation
Slide 2: Key Highlights
KEY HIGHLIGHTS CDMO agreement with a European Company Launched 12 Oncology products in Domestic Market Tech transfer for another 7 products for Domestic Market R&D developments of products in full swing which are going to be off patented in next 5 years. Our prime focus is to reach quality onco
Slide 3: Financial Highlights Y-o-Y Performance
Financial Highlights Y-o-Y Performance Medicamen Biotech Limited posts yearly results with a steady revenue growth of 4.81 % YoY REVENUE (YoY) 4.81% EBITDA (YoY) 24.30% PAT (YoY) 19.38%
Slide 4: Unique Value Propositions
UNIQUE VALUE PROPOSITIONS Reverse Diversified Differentiated Robust Integration product mix Dosage Forms Product In Oncology Pipeline Oncology- Breast cancer, Brain Tumor, Renal Cancer, MBL develops Prostate Cancer ETC. Expertise:- Launched 12 APIs 100% of its Cardiology TKI’s products D
Slide 5: Oncology Products Launched
ms q VIVO MEDICAMEN 5 Oncology ONCOLOGY PRODUCTS LAUNCHED apivo” aT . Pazocam = Capivo" Lenvamed ABTmed" axitinb” § Wasamed” Teme pen ETBmed’ Ledomed” AB-Taxomed" Fasvivo’ ache prten aan arcs) tinea sapere WO ve Fulvestrant Injection (250 mg’5 mb PPS Urea, Lactic Acid & Glycerin Cream Radiamed" frea
Slide 6: Products to be Launched in Current Financial Year
PRODUCTS TO BE LAUNCHED IN CURRENT FINANCIAL YEAR
Slide 7: State of Art – Manufacturing Facilities
State of Art – Manufacturing Facilities Research & Development General Formulation facility Centre Bhiwadi
Slide 8: State of Art – Manufacturing Facilities
State of Art – Manufacturing Facilities General Formulation facility Oncology Formulation facility Haridwar Unit-I Haridwar Unit-II
Slide 9: Registered Office
Registered Office: 1506, Chiranjiv Tower, 43 Nehru Place, New Delhi- 110019 Phone: 011-47589500 (30 Lines) Fax: 011-26213081 E-mail: cs@medicamen.com Website:www.medicamen.com